219 related articles for article (PubMed ID: 35469915)
1. Exploring the impact of physicochemical properties of liposomal formulations on their in vivo fate.
Sheikholeslami B; Lam NW; Dua K; Haghi M
Life Sci; 2022 Jul; 300():120574. PubMed ID: 35469915
[TBL] [Abstract][Full Text] [Related]
2. Factors affecting microencapsulation of drugs in liposomes.
Kulkarni SB; Betageri GV; Singh M
J Microencapsul; 1995; 12(3):229-46. PubMed ID: 7650588
[TBL] [Abstract][Full Text] [Related]
3. A Sojourn on Liposomal Delivery System: Recent Advances and Future Prospects.
Kaur S; Singh D
Assay Drug Dev Technol; 2023; 21(2):48-64. PubMed ID: 36856471
[No Abstract] [Full Text] [Related]
4. Liposome-based delivery system for vaccine candidates: constructing an effective formulation.
Giddam AK; Zaman M; Skwarczynski M; Toth I
Nanomedicine (Lond); 2012 Dec; 7(12):1877-93. PubMed ID: 23249332
[TBL] [Abstract][Full Text] [Related]
5. Intracellular and serum stability of liposomal 2',3'-dideoxycytidine. Effect of lipid composition.
Makabi-Panzu B; Gourde P; Désormeaux A; Bergeron MG
Cell Mol Biol (Noisy-le-grand); 1998 Mar; 44(2):277-84. PubMed ID: 9593578
[TBL] [Abstract][Full Text] [Related]
6. Exploring Cellular Interactions of Liposomes Using Protein Corona Fingerprints and Physicochemical Properties.
Bigdeli A; Palchetti S; Pozzi D; Hormozi-Nezhad MR; Baldelli Bombelli F; Caracciolo G; Mahmoudi M
ACS Nano; 2016 Mar; 10(3):3723-37. PubMed ID: 26882007
[TBL] [Abstract][Full Text] [Related]
7. Intracellular Distribution of Lipids and Encapsulated Model Drugs from Cationic Liposomes with Different Uptake Pathways.
Takikawa M; Fujisawa M; Yoshino K; Takeoka S
Int J Nanomedicine; 2020; 15():8401-8409. PubMed ID: 33149583
[TBL] [Abstract][Full Text] [Related]
8. Peritoneal retention of liposomes: Effects of lipid composition, PEG coating and liposome charge.
Dadashzadeh S; Mirahmadi N; Babaei MH; Vali AM
J Control Release; 2010 Dec; 148(2):177-86. PubMed ID: 20800629
[TBL] [Abstract][Full Text] [Related]
9. Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions.
Paramshetti S; Angolkar M; Talath S; Osmani RAM; Spandana A; Al Fatease A; Hani U; Ramesh KVRNS; Singh E
Life Sci; 2024 Jun; 346():122616. PubMed ID: 38599316
[TBL] [Abstract][Full Text] [Related]
10. Size dependent variations of phospholipid based vesicular drug carriers in systemic drug activity.
Mukherjee B; Mondal L; Chakraborty S; Paul P; Choudhury A; Bhattacharya S; Hossain CM
Curr Pharm Biotechnol; 2015; 16(4):380-91. PubMed ID: 25658382
[TBL] [Abstract][Full Text] [Related]
11. Effect of protein-encapsulation on thermal structural stability of liposome composed of glycosphingolipid/cholesterol/phospholipid.
Hirai M; Sato S; Kimura R; Hagiwara Y; Kawai-Hirai R; Ohta N; Igarashi N; Shimizu N
J Phys Chem B; 2015 Feb; 119(8):3398-406. PubMed ID: 25642599
[TBL] [Abstract][Full Text] [Related]
12. Liposomes in the Targeted Gene Therapy of Cancer: A Critical Review.
Akkewar A; Mahajan N; Kharwade R; Gangane P
Curr Drug Deliv; 2023; 20(4):350-370. PubMed ID: 35593362
[TBL] [Abstract][Full Text] [Related]
13. Anticancer double lipid prodrugs: liposomal preparation and characterization.
Arouri A; Mouritsen OG
J Liposome Res; 2011 Dec; 21(4):296-305. PubMed ID: 21438721
[TBL] [Abstract][Full Text] [Related]
14. Liposomal formulations of inflammatory bowel disease drugs: local versus systemic drug delivery in a rat model.
Kesisoglou F; Zhou SY; Niemiec S; Lee JW; Zimmermann EM; Fleisher D
Pharm Res; 2005 Aug; 22(8):1320-30. PubMed ID: 16078142
[TBL] [Abstract][Full Text] [Related]
15. Design of liposomes as drug delivery system for therapeutic applications.
Guimarães D; Cavaco-Paulo A; Nogueira E
Int J Pharm; 2021 May; 601():120571. PubMed ID: 33812967
[TBL] [Abstract][Full Text] [Related]
16. Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density.
Lee KD; Hong K; Papahadjopoulos D
Biochim Biophys Acta; 1992 Jan; 1103(2):185-97. PubMed ID: 1543703
[TBL] [Abstract][Full Text] [Related]
17. Theranostic Liposome-Nanoparticle Hybrids for Drug Delivery and Bioimaging.
Seleci M; Ag Seleci D; Scheper T; Stahl F
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671589
[TBL] [Abstract][Full Text] [Related]
18. Liposomes as biocompatible and smart delivery systems - the current state.
Dymek M; Sikora E
Adv Colloid Interface Sci; 2022 Nov; 309():102757. PubMed ID: 36152374
[TBL] [Abstract][Full Text] [Related]
19. Polysaccharide-modified liposomes and their application in cancer research.
Peng P; Chen Z; Wang M; Wen B; Deng X
Chem Biol Drug Des; 2023 Apr; 101(4):998-1011. PubMed ID: 36597375
[TBL] [Abstract][Full Text] [Related]
20. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
